Related Experiment Video
Updated: Aug 14, 2026

Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images SDM-PSI
Published on: November 27, 2019
Cerebral microbleeds: different prevalence, topography, and risk factors depending on dementia diagnosis—the
S Shams1, J Martola2, T Granberg2
1Clinical Science, Intervention, and Technology (S.S., J.M., T.G., M.S., L.C., P.A., M.K.-W.), Division of Medical Imaging and Technology, Karolinska Institute, Stockholm, Sweden Department of Radiology (S.S., J.M., T.G., M.S., L.C., P.A., M.K.-W.) sara.shams@ki.se.
Background And Purpose:
Cerebral microbleeds are thought to represent cerebral amyloid angiopathy when in lobar regions of the brain and hypertensive arteriopathy when in deep and infratentorial locations. By studying cerebral microbleeds, their topography, and risk factors, we aimed to gain an insight into the vascular and amyloid pathology of dementia diagnoses and increase the understanding of cerebral microbleeds in dementia.
Materials And Methods:
We analyzed 1504 patients (53% women; mean age, 63 ± 10 years; 10 different dementia diagnoses) in this study. All patients underwent MR imaging as part of the dementia investigation, and all their clinical parameters were recorded.
Results:
Among the 1504 patients with dementia, 22% had cerebral microbleeds. Cerebral microbleed topography was predominantly lobar (P = .01) and occipital (P = .007) in Alzheimer disease. Patients with cerebral microbleeds were significantly older (P < .001), were more frequently male (P < .001), had lower cognitive scores (P = .006), and more often had hypertension (P < .001). Risk factors for cerebral microbleeds varied depending on the dementia diagnosis. Odds ratios for having cerebral microbleeds increased with the number of risk factors (hypertension, hyperlipidemia, diabetes, male sex, and age 65 and older) in the whole patient group and increased differently in the separate dementia diagnoses.
Conclusions:
Prevalence, topography, and risk factors of cerebral microbleeds vary depending on the dementia diagnosis and reflect the inherent pathology of different dementia diagnoses. Because cerebral microbleeds are seen as possible predictors of intracerebral hemorrhage, their increasing prevalence with an increasing number of risk factors, as shown in our study, may require taking the number of risk factors into account when deciding on anticoagulant therapy in dementia.
Insights
Cerebral microbleeds (CMBs) prevalence and location differ across dementia types, reflecting underlying pathologies. Risk factors like hypertension significantly increase CMB occurrence, impacting treatment decisions for dementia patients.
Area of Science:
- Neurology
- Neuroimaging
- Vascular Dementia Research
Background:
- Cerebral microbleeds (CMBs) are associated with cerebral amyloid angiopathy in lobar regions and hypertensive arteriopathy in deep/infratentorial locations.
- Understanding CMB topography and risk factors offers insights into dementia-related vascular and amyloid pathologies.
Purpose of the Study:
- To investigate the topography and risk factors of cerebral microbleeds (CMBs) in patients with various dementia diagnoses.
- To enhance comprehension of CMBs' role in the context of dementia.
Main Methods:
- Analysis of 1504 dementia patients (mean age 63 ± 10 years) with 10 different dementia diagnoses.
- Review of MR imaging and clinical parameters for all participating patients.
Main Results:
- 22% of dementia patients exhibited CMBs, with predominantly lobar and occipital topography in Alzheimer disease.
- CMB patients were older, more frequently male, had lower cognitive scores, and higher rates of hypertension.
- Risk factors for CMBs varied by dementia diagnosis, with odds increasing with the number of factors (hypertension, hyperlipidemia, diabetes, male sex, age ≥65).
Conclusions:
- CMB prevalence, topography, and risk factors are diagnosis-dependent, mirroring specific dementia pathologies.
- Increasing CMB prevalence with multiple risk factors suggests considering these factors when initiating anticoagulant therapy in dementia patients.
- CMBs may serve as predictors of intracerebral hemorrhage, highlighting the importance of risk factor assessment.
More Related Videos
Related Concept Videos
Dementia
The progression of dementia is generally gradual.
Hemorrhagic Stroke l: Introduction
Alzheimer Disease l: Introduction
Dementia l: Introduction

